Literature DB >> 9844793

Effect of amantadine on sexual dysfunction in neuroleptic-treated male schizophrenic patients.

A Valevski1, I Modai, E Zbarski, Z Zemishlany, A Weizman.   

Abstract

Twelve male schizophrenic outpatients treated with neuroleptics took part in an open-label drug study to assess the impact of co-administration of amantadine hydrochloride (100 mg daily for 6 weeks) on sexual function. Amantadine improved the patients' scores in three out of four areas of sexual function: desire (p < 0.02), erection (p < 0.05), and satisfaction from sexual performance (p < 0.05); there was no change in ejaculatory function. Amantadine may be effective for improving sexual function in male schizophrenic patients receiving neuroleptic medication.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9844793

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  5 in total

Review 1.  The facts about sexual (Dys)function in schizophrenia: an overview of clinically relevant findings.

Authors:  Marrit K de Boer; Stynke Castelein; Durk Wiersma; Robert A Schoevers; Henderikus Knegtering
Journal:  Schizophr Bull       Date:  2015-02-25       Impact factor: 9.306

Review 2.  Management of sexual dysfunction due to antipsychotic drug therapy.

Authors:  Hannah M Schmidt; Mathias Hagen; Levente Kriston; Karla Soares-Weiser; Nicola Maayan; Michael M Berner
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14

Review 3.  Antipsychotic-induced hyperprolactinemia: synthesis of world-wide guidelines and integrated recommendations for assessment, management and future research.

Authors:  Jasmin Grigg; Roisin Worsley; Caroline Thew; Caroline Gurvich; Natalie Thomas; Jayashri Kulkarni
Journal:  Psychopharmacology (Berl)       Date:  2017-09-09       Impact factor: 4.530

Review 4.  The drug treatment of delayed ejaculation.

Authors:  Ibrahim A Abdel-Hamid; Moustafa A Elsaied; Taymour Mostafa
Journal:  Transl Androl Urol       Date:  2016-08

Review 5.  Amantadine: reappraisal of the timeless diamond-target updates and novel therapeutic potentials.

Authors:  Wojciech Danysz; Andrzej Dekundy; Astrid Scheschonka; Peter Riederer
Journal:  J Neural Transm (Vienna)       Date:  2021-02-23       Impact factor: 3.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.